MyFinsight
Home
Blog
About
Contact
Download
Download image
Product revenue, net
$226,651K
Gain on divestiture
$52,553K
Income from operations
$196,609K
Total interest and
other, net
-$42,564K
Total operating costs
and expenses
$30,042K
Interest expense
$7,816K
Interest income and other
income (expenses), net
$2,173K
Income before income
taxes
$239,173K
Investment income in
unconsolidated variable...
$2,483K
Selling, general and
administrative
$14,849K
Cost of goods sold
$13,454K
Research and development
$1,739K
Income from
discontinued operations, net...
$241,656K
Net income (loss)
$183,452K
Loss from continuing
operations
-$58,204K
Benefit from income
taxes
-$90K
Europe
$5,055K
JP
$793K
Loss from continuing
operations before income...
-$58,294K
Drug Product Revenue
$5,848K
Development And Other
Revenue
$592K
Loss from operations
-$45,895K
Total interest and
other, net
-$12,399K
Total revenue
$6,440K
Interest income and other
income (expenses), net
$2,943K
Total operating costs
and expenses
$52,335K
Interest expense
$8,759K
Loss on debt
extinguishments
-$6,583K
Selling, general and
administrative
$27,709K
Research and development
$23,517K
Cost of goods sold
$556K
Restructuring charge
$553K
Back
Back
Income Statement
source: myfinsight.com
KYNTRA BIO, INC. (KYNB)
KYNTRA BIO, INC. (KYNB)